Nexplanon is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Etonogestrel.
Product ID | 78206-145_2b6805f7-1ff5-40bf-a028-a173a7fdb580 |
NDC | 78206-145 |
Product Type | Human Prescription Drug |
Proprietary Name | Nexplanon |
Generic Name | Etonogestrel |
Dosage Form | Implant |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2021-06-01 |
Marketing Category | NDA / |
Application Number | NDA021529 |
Labeler Name | Organon LLC |
Substance Name | ETONOGESTREL |
Active Ingredient Strength | 68 mg/1 |
Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0052-4330 | Nexplanon | etonogestrel |
78206-145 | Nexplanon | etonogestrel |
0052-0272 | IMPLANON | etonogestrel |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NEXPLANON 79028211 3362650 Live/Registered |
MERCK SHARP & DOHME B.V. 2006-05-04 |